155 results on '"Yeo, Charles J."'
Search Results
2. Impact of antecolic vs transmesocolic reconstruction on delayed gastric emptying following pancreaticoduodenectomy
3. A brief history of the office of the Surgeon General and the 2 surgeons who have held the position
4. Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS)
5. Effect of Hypercapnia, an Element of Obstructive Respiratory Disorder, on Pancreatic Cancer Chemoresistance and Progression
6. Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential
7. Enhancing Patient Outcomes while Containing Costs after Complex Abdominal Operation: A Randomized Controlled Trial of the Whipple Accelerated Recovery Pathway
8. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance
9. Comprehensive Multicenter Graduate Surgical Education Initiative Incorporating Entrustable Professional Activities, Continuous Quality Improvement Cycles, and a Web-Based Platform to Enhance Teaching and Learning
10. A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2
11. Vascular Resections During the Whipple Procedure
12. Pancreatic anastomosis after pancreatoduodenectomy: A position statement by the International Study Group of Pancreatic Surgery (ISGPS)
13. Pneumonia is associated with a high risk of mortality after pancreaticoduodenectomy
14. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After
15. Definition and classification of chyle leak after pancreatic operation: A consensus statement by the International Study Group on Pancreatic Surgery
16. Fluid Restriction During Pancreaticoduodenectomy: Is It Effective in Reducing Postoperative Complications?
17. Minimally Invasive Esophagectomy Provides Significant Survival Advantage Compared with Open or Hybrid Esophagectomy for Patients with Cancers of the Esophagus and Gastroesophageal Junction
18. A Prospective, Randomized, Double-Blind, Placebo Controlled Trial on the Efficacy of Ethanol Celiac Plexus Neurolysis in Patients with Operable Pancreatic and Periampullary Adenocarcinoma
19. CHAPTER 61 - Pancreatic cancer: Epidemiology
20. Corrigendum to “The 2016 update of the International Study Group (ISGPF) definition and grading of postoperative pancreatic fistula: eleven years after.” Surgery 2017. Mar; 161 (3):584–591. Epub Dec 28, 2016
21. A Progressive Postresection Walking Program Significantly Improves Fatigue and Health-Related Quality of Life in Pancreas and Periampullary Cancer Patients
22. Oncologic Efficacy Is Not Compromised, and May Be Improved with Minimally Invasive Esophagectomy
23. Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma
24. Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma
25. Does Type of Pancreaticojejunostomy after Pancreaticoduodenectomy Decrease Rate of Pancreatic Fistula? A Randomized, Prospective, Dual-Institution Trial
26. Genotyping and Expression Analysis of IDO2 in Human Pancreatic Cancer: A Novel, Active Target
27. Impact of Obesity on Perioperative Morbidity and Mortality after Pancreaticoduodenectomy
28. Cumulative Operative Experience Is Decreasing During General Surgery Residency: A Worrisome Trend for Surgical Trainees?
29. Expression of Indoleamine 2,3-Dioxygenase in Metastatic Pancreatic Ductal Adenocarcinoma Recruits Regulatory T Cells to Avoid Immune Detection
30. Chapter 55 - Pancreas Divisum
31. Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasia
32. Antihypertensives as Novel Antineoplastics: Angiotensin-I-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockers in Pancreatic Ductal Adenocarcinoma
33. Initiation of a Critical Pathway for Pancreaticoduodenectomy at an Academic Institution—the First Step in Multidisciplinary Team Building
34. Biochemical Markers Predict Morbidity and Mortality after Pancreaticoduodenectomy
35. Pancreaticoduodenectomy with Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma
36. Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes
37. 1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
38. Does Pancreatic Duct Stenting Decrease the Rate of Pancreatic Fistula Following Pancreaticoduodenectomy? Results of a Prospective Randomized Trial
39. Hospital Readmission After Pancreaticoduodenectomy
40. Retroperitoneal Paraganglioma: Single-Institution Experience and Review of the Literature
41. Pancreaticoduodenectomy in the Very Elderly
42. Differences in Survival for Patients With Resectable Versus Unresectable Metastases From Pancreatic Islet Cell Cancer
43. Contributors
44. Chapter 114 - Operative Management of Bile Duct Strictures
45. Chapter 93 - Pseudocysts and Other Complications of Pancreatitis
46. Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion
47. Pancreaticoduodenectomy With or Without Distal Gastrectomy and Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma—Part 3: Update on 5-Year Survival
48. Survival After Gastric Adenocarcinoma Resection: Eighteen-Year Experience at a Single Institution
49. Hypercalcemia and pancreatic endocrine neoplasia with elevated PTH-rP: report of two new cases and subject review
50. Peripancreatic tuberculosis mimicking pancreatic neoplasia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.